Carolina Wealth Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,508
Closed -$272K 265
2022
Q2
$272K Sell
1,508
-154
-9% -$27.6K 0.18% 65
2022
Q1
$284K Buy
1,662
+288
+21% +$54.3K 0.18% 57
2021
Q4
$288K Buy
1,374
+1,029
+298% +$213K 0.16% 47
2021
Q3
$66K Buy
+345
New +$84.8K 0.04% 122
2020
Q1
Sell
-517
Closed -$57K 192
2019
Q4
$57K Buy
+517
New +$50K 0.05% 64

Other funds holding MED

Carolina Wealth Advisors's MED Position: Q3 2022 in Review

Carolina Wealth Advisors sold out of Medifast (MED) in Q3 2022, closing a stake of 1,508 shares — an estimated $272K sold.

Carolina Wealth Advisors first reported a position in MED in Q4 2019 and held it in 5 quarters. The position peaked at $288K in Q4 2021. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Carolina Wealth Advisors reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Carolina Wealth Advisors sold 1,508 Medifast shares in Q3 2022, an estimated $272K.
  • Carolina Wealth Advisors first reported a position in Medifast in Q4 2019 and held it in 5 quarters.
  • Carolina Wealth Advisors's Medifast position peaked at $288K in Q4 2021.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Carolina Wealth Advisors's 13F filing for Q3 2022, filed 14 Oct 2022.